​

Funding Round

Series A - Prologue Medicines

Series A - Prologue Medicines

Investment Firm

Overview

Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.

Announced Date

May 07, 2024

Funding Type

Series A

Highlights

Location

N/A

Social

Investor Lead

Flagship Pioneering

Flagship Pioneering

Flagship Pioneering is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

1

Investor Name
Participant InvestorFlagship Pioneering

Round Details and Background

Prologue Medicines raised $50000000 on 2024-05-07 in Series A

Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 07, 2024
Series A - Prologue Medicines
1-50.0M

Recent Activity

There is no recent news or activity for this profile.